Rethinking pediatric clinical trials: guidelines from pediatric experts
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
2021 Customer Satisfaction Survey
90.8% of our clients are likely to recommend Kayentis to a colleague or a friend.
Ensure the success of your decentralized clinical trials: select Kayentis!
Learn more:
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Last update : 3 March 2022